## NKE: NIKE, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -11.8% below STRENGTH zone (4.0-10.0%); PEG 2.70 fails VALUE criteria (<1.0); RSI 30 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge. Caution: momentum weakening (-15.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($53.30)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 2)

**1. Nike, Insmed, And Arm Are Among Top 10 Large Cap Losers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio? - ARM Holdings (NASDAQ:ARM), BitMine Immersion (AMEX:BMNR), Insmed (NASDAQ:INSM), Lennar (NYSE:LEN)**
- Source: Benzinga | 20251222T111045 | Bearish | Relevance: 94%
- This article identifies the top ten large-cap stock losers from the week of December 15-19, 2025, including Nike, Arm Holdings, and Insmed. Reasons for their declines range from earnings misses and analyst downgrades to issues with clinical trials and broader market volatility. Investors are prompted to check if any of these underperforming stocks are part of their current portfolio.

**2. Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts**
- Source: ts2.tech | 20251222T200908 | Somewhat-Bearish | Relevance: 87%
- Academy Sports and Outdoors (ASO) stock declined on December 22, 2025, primarily due to sector-wide pressure following disappointing results from Nike, which impacted athletic retail exposure. Despite ASO's recent Q3 fiscal 2025 report showing improved profitability, narrowed full-year outlook, and gross margin expansion, investor caution persists regarding comparable sales and brand-driven demand signals. Analysts maintain a "Hold" consensus, with price targets indicating potential upside but also reflecting unresolved fundamental debates in the retail sector.

**3. Why Academy Sports (ASO) Shares Are Trading Lower Today**
- Source: Finviz | 20251222T115600 | Bearish | Relevance: 81%
- Shares of Academy Sports & Outdoors (NASDAQ:ASO) fell 3.7% today after athletic retail sector bellwether Nike reported disappointing results, sparking concerns about potential weaker sales or increased promotions for other retailers. This dip follows an 11% plunge in Nike's stock, driven by shrinking gross margins and reduced revenue in Greater China. Despite this, Academy Sports's shares show high volatility, and a recent "Outperform" rating from Telsey Advisory Group and a board expansion had previously boosted market sentiment.

**4. Jim Cramer on FedEx: "Stay Long, Comes Down, Buy More"**
- Source: Finviz | 20251223T060827 | Somewhat-Bullish | Relevance: 65%
- Jim Cramer highlighted FedEx (NYSE: FDX) as a "remarkable company," praising CEO Raj Subramaniam's turnaround efforts and strategic pivot to the business-to-business space, especially in pharma delivery and data centers. Despite tariffs and a slowing U.S. economy, Cramer noted FedEx's strong performance and advised investors to "stay long" and "buy more" if the stock dips. He emphasized the company's strong competitive moat and successful unheralded move into a sticky and profitable business model.

**5. Jim Cramer Applauds FedEx for a Strong Quarter**
- Source: Finviz | 20251221T102600 | Neutral | Relevance: 63%
- Jim Cramer praised FedEx's latest quarterly results, highlighting higher-than-expected revenues and an earnings beat. He noted the company's successful cost-cutting efforts and optimized delivery network, leading to a raised full-year forecast. Cramer also believes FedEx is well-positioned for growth, especially with the surge in e-commerce and its impending freight division spin-off.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 13)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | UBS | $62 | $71 | -13% |
| 2025-12-19 | Citigroup | $65 | $70 | -7% |
| 2025-12-19 | Barclays | $64 | $70 | -9% |
| 2025-12-19 | Truist Securiti | $70 | $85 | -18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | UBS | main | Neutral |
| 2025-12-19 | Citigroup | main | Neutral |
| 2025-12-19 | Barclays | main | Equal-Weight |
| 2025-12-19 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($2.16M) |
| Sells | 4 ($6.26M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (+1.3%)
- Blackrock Inc.: 7.7% (-0.1%)
- State Street Corpora: 4.9% (-1.9%)
- Capital World Invest: 3.5% (+0.7%)
- JPMORGAN CHASE & CO: 2.7% (+72.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-15.3% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $6.3M in recent transactions.
3. Long-term trend broken: trading 14.4% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.70 signals overvaluation risk, limited margin of safety. Forward P/E 23.8x attractive for 51% earnings growth. Analyst sentiment negative (13 target cuts vs 0 raises). Insider selling cluster ($6.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $84.8B |
| Beta | 1.29 |
| 52W Range | $52.28 - $82.44 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.70 |
| Forward P/E | 23.8 |
| Current P/E | 35.8 |
| YoY Growth | 50.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.5% to -11.8% (-15.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 15.8pp (needs >4.0% for momentum thesis). AM_20 at -10.8% indicates price below own 20MA trend. Underperforming sector by 12.8pp, stock-specific weakness. Below SMA200 (0.86x), long-term trend not supportive. MACD histogram bearish (-0.93), momentum weakening. RSI oversold at 30, potential bounce setup. Elevated volume (3.3x 20MA), institutional activity likely. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -11.75% (CS: 1) | Weak |
| RSI_14 | 29.9 | Oversold |
| MACD Histogram | -0.93 | Bearish |
| vs SMA20 | 0.891x | Below |
| vs SMA50 | 0.887x | Below |
| vs SMA200 | 0.856x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $57.34
- **Stop Loss:** $53.30 (7.0% risk)
- **Target:** $61.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 222
- **Position Value:** $12,729.48
- **Portfolio %:** 12.73%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.37 | $0.53 | +41.9% |
| 2025Q3 | $0.27 | $0.49 | +84.5% |
| 2025Q2 | $0.12 | $0.14 | +13.5% |
| 2025Q1 | $0.28 | $0.54 | +94.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*